A glance at adenosine receptors: Novel target for antitumor therapy

Pharmacology and Therapeutics

Volumn 100, Issue 1, 2003, Pages 31-48

  Merighi, Stefania ^a   Mirandola, Prisco ^b   Varani, Katia ^a   Gessi, Stefania ^a   Leung, Edward ^c   Baraldi, Pier Giovanni ^d   Tabrizi, Mojgan Aghazadeh ^d   Borea, Pier Andrea ^a,d  

^a Dept of Clin/Experimental Medicine ^*  (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c King Pharmaceuticals   (United States)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

Adenosine; Adenosine receptors; Antitumor therapy; Apoptosis; Proliferation; Tumor

Indexed keywords

ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE DEAMINASE; ADENOSINE RECEPTOR; CISPLATIN; CYCLOPHOSPHAMIDE; DNA FRAGMENT; ENDOTHELIAL CELL GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLISOPROPYLADENOSINE; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; WNT PROTEIN;

ANGIOGENESIS; APOPTOSIS; ASTROCYTOMA CELL; BINDING AFFINITY; BONE MARROW CELL; BRAIN HEMORRHAGE; CANCER CELL; CARCINOGENESIS; CELL DEATH; CELL GROWTH; CELL METABOLISM; CELL POPULATION; CELL PROTECTION; CELL SURFACE; CELL SURVIVAL; CELL TYPE; CHRONIC LYMPHATIC LEUKEMIA; CULTURE MEDIUM; DENDRITIC CELL; DNA SYNTHESIS; DOWN REGULATION; DRUG TARGETING; EMBRYO DEVELOPMENT; FIBROBLAST; GENETIC TRANSCRIPTION; GROWTH REGULATION; HEART PROTECTION; HUMAN; HYPOXIC CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; KIDNEY CELL; LEUKEMIA; MACROPHAGE; MAST CELL; MELANOMA; MONOCYTE; MONOCYTIC LEUKEMIA; NEUROBLASTOMA; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RADIATION PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TISSUE INJURY; TUMOR GROWTH; UMBILICAL VEIN; WOUND HEALING;

EID: 0141673290     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(03)00084-6     Document Type: Review

References (156)

1. Abbracchio M.P., Burnstock G. Purinergic signalling: Pathophysiological roles. Jpn J Pharmacol. 78:1998;113-145.
2. 3 receptors in rat brain. Mol Pharmacol. 48:1995;1038-1045.
3. 3 adenosine receptor mediates cell spreading, reorganization of actin cytoskeleton, and distribution of Bcl-XL: Studies in human astroglioma cells. Biochem Biophys Res Commun. 241:1997;297-304.
4. 3 receptors and viability of astrocytes. Drug Dev Res. 45:1998;379-386.
5. 3 adenosine receptor induces cytoskeleton rearrangement in human astrocytoma cells via a specific action on Rho proteins. Ann NY Acad Sci. 939:2001;63-73.
6. 2A receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency. Blood. 95:2000;3859-3867.
7. 3 receptor-induced apoptosis. J Mol Neurosci. 17:2001;285-292.
8. 2A-receptor-gene-deficient mice. Biochem J. 354:2001;123-130.
9. 2A receptors on nerve growth factor-induced phosphorylation of extracellular regulated kinases 1/2 in PC12 cells. Neurosci Lett. 292:2000;183-186.
10. 2A receptors upon NGF-induced differentiation of PC12 cells. Neuropharmacology. 36:1997;1319-1326.
11. Bajaj S., Insel J., Quagliata F., Hirschhorn R., Silber R. Adenosine and adenosine analogues are more toxic to chronic lymphocytic leukemia than to normal lymphocytes. Blood. 62:1983;75-80.
12. Bakris G.L., Sauter E.R., Hussey J.L., Fisher J.W., Gaber A.O., Winsett R. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. N Engl J Med. 323:1990;86-90.
13. 3 receptor antagonists. Trends Pharmacol Sci. 21:2000;456-459.
14. 3 adenosine receptor ligands: History and perspectives. Med Res Rev. 20:2000;103-128.
15. Barbieri D., Abbracchio M.P., Salvioli S., Monti D., Cossarizza A., Ceruti S., Brambilla R., Cattabeni F., Jacobson K.A., Franceschi C. Apoptosis by 2-chloro-2′-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells. Neurochem Int. 32:1998;493-504.
16. 3 adenosine receptor agonists. Neoplasia. 3:2001;125-131.
17. 1 receptor in the rat kidney. Eur J Pharmacol. 442:2002;251-264.
18. Blay J., White T.D., Hoskin D.W. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res. 57:1997;2602-2605.
19. 3 adenosine receptor affects cell cycle progression and cell growth. Naunyn-Schmiedeberg's Arch Pharmacol. 361:2000;225-234.
20. Burnstock G. Purinergic signalling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol. 22:2002;364-373.
21. 2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion. J Vasc Surg. 34:2001;482-488.
22. Cazzola M., Guarnone R., Cerani P., Rovati A., Ascari E. Congenital erythropoietin-dependent erythrocytosis responsive to theophylline treatment. Blood. 91:1998;360-361.
23. Ceruti S., Barbieri D., Veronese E., Cattabeni F., Cossarizza A., Giammarioli A.M., Malori W., Franceschi C., Abbracchio M.P. Different pathways of apoptosis revealed by 2-chloro-adenosine and deoxy-D-ribose in mammalian astroglial cells. J Neurosci Res. 47:1997;372-383.
24. Colquhoun A., Newsholme E.A. Inhibition of human tumour cell proliferation by analogues of adenosine. Cell Biochem Funct. 15:1997;135-139.
25. Conrad P.W., Freeman T.L., Beitner-Johnson D., Millhorn D.E. EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J Biol Chem. 274:1999;33709-33713.
26. Cross H.R., Murphy E., Black R.G., Auchampach J., Steenbergen C. Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts. Am J Physiol Heart Circ Physiol. 283:2002;H1562-H1568.
27. D'Ancona S., Ragazzi E., Fassina G., Mazzo M., Gusella M., Berti T. Effect of dipyridamole, 5′-(N-ethyl)-carboxamidoadenosine and 1,3-dipropyl-8-(2-amino-4-chlorophenyl)-xanthine on LOVO cell growth and morphology. Anticancer Res. 14:1994;93-97.
28. Dawicki D.D., Chatterjee D., Wyche J., Rounds S. Extracellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cells. Am J Physiol. 273:1997;L485-L494.
29. 1 receptor and P2Y2-purinoceptor-mediated activation of the mitogen-activated protein kinase cascade in transfected CHO cells. Br J Pharmacol. 124:1998;1491-1499.
30. Di Iorio P., Kleywegt S., Ciccarelli R., Traversa U., Andrew C.M., Crocker C.E., Werstiuk E.S., Rathbone M.P. Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Glia. 38:2002;179-190.
31. Dubey R.K., Gillespie D.G., Jackson E.K. Adenosine induces nitric oxide synthesis in vascular smooth muscle cells. Hypertension. 28:1996;7.
32. 2B receptors. Hypertension. 31:1998;943-948.
33. 2B receptors. Hypertension. 31:1998;516-521.
34. Dubey R.K., Gillespie D.G., Jackson E.K. Adenosine inhibits collagen and total protein synthesis in vascular smooth muscle cells. Hypertension. 33:1999;190-194.
35. 2B receptors mediate antimitogenesis in vascular smooth muscle cells. Hypertension. 35:2000;267-272.
36. 2b receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts. Hypertension. 37:2001;716-721.
37. 2B adenosine receptors stimulate growth of porcine and rat arterial endothelial cells. Hypertension. 39:2002;530-535.
38. Ethier M.F., Dobson J.G. Jr. Adenosine stimulation of DNA synthesis in human endothelial cells. Am J Physiol. 272:1997;H1470-H1479.
39. Ethier M.F., Chander V., Dobson J.G. Jr. Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol. 265:1993;H131-H138.
40. 2B receptor-mediated interleukin-8 production in human mast cells. Mol Pharmacol. 55:1999;726-734.
41. 2B receptors in angiogenic factor regulation. Circ Res. 90:2002;531-538.
42. 2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J Neurochem. 66:1996;1426-1431.
43. 2B receptor activation of erythropoietin production. Am J Physiol Renal Physiol. 281:2001;F826-F832.
44. Fishman P., Bar-Yehuda S., Vagman L. Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. Cancer Res. 58:1998;3181-3187.
45. 3 adenosine receptors. J Cell Physiol. 183:2000;393-398.
46. 3 adenosine receptor. Eur J Cancer. 36:2000;1452-1458.
47. 3 adenosine receptor as a new target for cancer therapy and chemoprotection. Exp Cell Res. 269:2001;230-236.
48. 3 adenosine receptor as a target for cancer therapy. Anticancer Drugs. 13:2002;437-443.
49. Fishman P., Madi L., Bar-Yehuda S., Barer F., Del Valle L., Khalili K. Evidence for involvement of Wnt signalling pathway in IB-MECA mediated suppression of melanoma cells. Oncogene. 21:2002;4060-4064.
50. Folkman J. Angiogenesis. Holland J.F., Frei E. III, East R., Kufe D., Morton D., Weichselbaum R. Cancer Medicine. 4th ed. 1997;181 Williams & Wilkins, Baltimore.
51. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.N., Linden J. International Union of Pharmacology 2001: XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 53:2001;527-552.
52. Fredholm B.B., Irenius E., Kull B., Schulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol. 61:2001;443-448.
53. 2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. Cross-talk between cyclic AMP and protein kinase c pathways. J Biol Chem. 274:1999;5972-5980.
54. 3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol. 59:2001;76-82.
55. 1-adenosine receptor in DDT(1)MF-2 cells. Br J Pharmacol. 130:2000;867-874.
56. Gervitz L.M., Nalbant D., Williams S.C., Fowler J.C. Adenosine-mediated activation of Akt/protein kinase B in the rat hippocampus in vitro and in vivo. Neurosci Lett. 328:2002;175-179.
57. 3 adenosine receptors in Jurkat T cells. Br J Pharmacol. 134:2001;116-126.
58. 3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. Mol Pharmacol. 61:2002;415-424.
59. Grant M.B., Tarnuzzer R.W., Caballero S., Ozeck M.J., Davis M.I., Spoerri P.E., Feoktistov I., Biaggioni I., Shryock J.C., Belardinelli L. Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res. 85:1999;699-706.
60. 2B adenosine receptor stimulation. Invest Ophthalmol Vis Sci. 42:2001;2068-2073.
61. Hale A.J., Smith C.A., Sutherland L.C., Stoneman V.E., Longthorne V.L., Culhane A.C., Williams G.T. Apoptosis: Molecular regulation of cell death. Eur J Biochem. 236:1996;1-26.
62. 2A receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation. J Pharmacol Exp Ther. 294:2000;1034-1042.
63. 2A receptor-dependent and independent mechanisms. FASEB J. 13:2000;2065-2074.
64. Hasko G., Deitch E.A., Szabo C., Nemeth Z.H., Vizi E.S. Adenosine: A potential mediator of immunosuppression in multiple organ failure. Curr Opin Pharmacol. 2:2002;440-444.
65. Heidemann H.T., Muller S., Mertins L., Stepan G., Hoffmann K., Ohnhaus E.E. Effect of aminophylline on cisplatin nephrotoxicity in the rat. Br J Pharmacol. 97:1989;313-318.
66. 2 receptors. J Biol Chem. 277:2002;18091-18097.
67. 2A receptor to inhibition of the mitogen-activated protein kinase cascade in Chinese hamster ovary cells. Biochem J. 316:1996;81-86.
68. Hoskin D.W., Reynolds T., Blay J. Adenosine as a possible inhibitor of killer T-cell activation in the microenvironment of solid tumours. Int J Cancer. 59:1994;854-855.
69. 3 receptor to prevent the induction of murine anti-CD3-activated killer T cells. Int J Cancer. 99:2002;386-395.
70. 2A adenosine receptors antagonizes apoptosis due to serum deprivation in PC12 cells. J Biol Chem. 276:2001;13838-13846.
71. Jacobson K.A., Hoffmann C., Cattabeni F., Abbracchio M.P. Adenosine-induced cell death: Evidence for receptor-mediated signalling. Apoptosis. 4:1999;197-211.
72. 3 adenosine receptor agonists. J Biol Chem. 275:2000;30272-30279.
73. 2B adenosine receptors. Biochem Pharmacol. 61:2001;657-663.
74. Kerr J.F., Winterford C.M., Harmon B.V. Apoptosis. Its significance in cancer and cancer therapy. Cancer. 73:1994;2013-2026.
75. 1 receptors in colorectal cancer and related mucosa. Cancer Lett. 106(1):1996;17-21.
76. Kim S.G., Ravi G., Hoffmann C., Jung Y.J., Kim M., Chen A., Jacobson K.A. p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA. Biochem Pharmacol. 63:2002;871-880.
77. King K.L., Cidlowski J.A. Cell cycle and apoptosis: Common pathways to life and death. J Cell Biochem. 58:1995;175-180.
78. Klinger M., Freissmuth M., Nanoff C. Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal. 14:2002;99-108.
79. Klotz K.N. Adenosine receptors and their ligands. Naunyn-Schmiedeberg's Arch Pharmacol. 362:2000;382-391.
80. Knight R.J., Collis M.G., Yates M.S., Bowmer C.J. Amelioration of cisplatin-induced acute renal failure with 8-cyclopentyl-1,3-dipropylxanthine. Br J Pharmacol. 104:1991;1062-1068.
81. 2A receptor gene by hypoxia in PC12 cells. A potential role in cell protection. J Biol Chem. 274:1999;20358-20365.
82. 2A receptor. J Physiol. 508:1998;95-107.
83. 3 receptor agonists. Biochem Biophys Res Commun. 219:1996;904-910.
84. 2A purinergic receptor-mediated signalling in murine T cells. J Biol Chem. 272:1997;25881-25889.
85. 3 receptors. Am J Physiol Renal Physiol. 278:2000;F380-F387.
86. 2a adenosine receptors. Am J Physiol Renal Physiol. 282:2002;F844-F852.
87. Lee J.E., Bokoch G., Liang B.T. A novel cardioprotective role of RhoA: New signalling mechanism for adenosine. FASEB J. 15:2001;1886-1894.
88. 2A receptor agonists and endotoxin. Am J Pathol. 160:2002;2231-2244.
89. Leist M., Jaattela M. Four deaths and a funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell Biol. 2:2001;589-598.
90. Linden J. Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol. 41:2001;775-787.
91. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res. 28:1994;1057-1061.
92. Liu J., Tian Z., Gao B., Kunos G. Dose-dependent activation of antiapoptotic and proapoptotic pathways by ethanol treatment in human vascular endothelial cells: Differential involvement of adenosine. J Biol Chem. 277:2002;20927-20933.
93. Lutty G.A., McLeod D.S. Retinal vascular development and oxygen-induced retinopathy: A role for adenosine. Prog Retin Eye Res. 22:2003;95-111.
94. Lutty G.A., Mathews M.K., Merges C., McLeod D.S. Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation. Curr Eye Res. 17:1998;594-607.
95. 2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Ann Neurol. 49:2001;727-735.
96. Merighi S., Varani K., Gessi S., Cattabriga E., Iannotta V., Ulouglu C., Leung E., Borea P.A. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. Br J Pharmacol. 34:2001;1215-1226.
97. Merighi S., Mirandola P., Milani D., Varani K., Gessi S., Klotz K.N., Leung E., Baraldi P.G., Borea P.A. Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. J Invest Dermatol. 119:2002;923-933.
98. 3 adenosine receptor. Biochem Pharmacol. 63:2002;157-161.
99. Michel P.P., Marien M., Ruberg M., Colpaert F., Agid Y. Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes. J Neurochem. 72:1999;2074-2082.
100. Montesinos M.C., Gadangi P., Longaker M., Sung J., Levine J., Nilsen D., Reibman J., Li M., Jiang C.K., Hirschhorn R., Recht P.A., Ostad E., Levin R.I., Cronstein B.N. Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med. 186:1997;1615-1620.
101. 2A receptors. Am J Pathol. 160:2002;2009-2018.
102. Mundell S.J., Kelly E. Evidence for co-expression and desensitization of A2a and A2b adenosine receptors in NG108-15 cells. Biochem Pharmacol. 55:1998;595-603.
103. Nagashima K., Karasawa A. Modulation of erythropoietin production by selective adenosine agonists and antagonists in normal and anemic rats. Life Sci. 59:1996;761-771.
104. 3 adenosine receptor. J Cell Physiol. 186:2001;19-23.
105. 2A adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol. 279:2000;F809-F818.
106. 2B receptors mediated nitric oxide production in coronary artery endothelial cells. Gen Pharmacol. 35:2000;171-177.
107. 2A adenosine receptors: An apparent paradox. Drug Dev Res. 45:1998;387-393.
108. 2A receptors and neuroprotection. Ann NY Acad Sci. 825:1997;30-48.
109. Panther E., Idzko M., Herouy Y., Rheinen H., Gebicke-Haerter P.J., Mrowietz U., Dichmann S., Norgauer J. Expression and function of adenosine receptors in human dendritic cells. FASEB J. 15:2001;1963-1970.
110. 2b purinoceptor. Circ Res. 86:2000;76-85.
111. Pospisil M., Hofer M., Znojil V., Vacha J., Netikova J., Hola J. Synergistic effect of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice. Blood. 86:1995;3692-3697.
112. Pospisil M., Hofer M., Znojil V., Neitikova J., Vacha J., Hola J., Vacek A. Granulocyte colony-stimulating factor and drugs elevating extracellular adenosine synergize to enhance haematopoietic reconstitution in irradiated mice. Eur J Haematol. 60:1998;172-180.
113. Pospisil M., Hofer M., Vacek A., Netikova J., Hola J., Znojil V., Weiterova L. Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil. Exp Hematol. 29:2001;557-562.
114. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 50:1998;413-492.
115. Rathbone M.P., Middlemiss P.J., Gysbers J.W., DeForge S., Costello P., Del Maestro R.F. Purine nucleosides and nucleotides stimulate proliferation of a wide range of cell types. In Vitro Cell Dev Biol. 28A:1992;529-536.
116. Rathbone M.P., Middlemiss P.J., Kim J.K., Gysbers J.W., DeForge S.P., Smith R.W., Hughes D.W. Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells. Neurosci Res. 13:1992;1-17.
117. 1 receptor in DDT(1)MF-2 cells. Eur J Pharmacol. 413:2001;151-161.
118. 3 receptor activation during hypoxia in isolated rat cardiac myocytes. Mol Cell Biochem. 217:2001;143-152.
119. Sandberg G. Regulation of thymocyte proliferation by endogenous adenosine and adenosine deaminase. Int J Immunopharmacol. 5:1983;259-265.
120. Schrier S.M., van Tilburg E.W., van der Meulen H., Ijzerman A.P., Mulder G.J., Nagelkerke J.F. Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: Studies on involvement of adenosine receptors and adenosine uptake. Biochem Pharmacol. 61:2001;417-425.
121. Schubert P., Morino T., Miyazaki H., Ogata T., Nakamura Y., Marchini C., Ferroni S. Cascading glia reactions: A common pathomechanism and its differentiated control by cyclic nucleotide signalling. Ann NY Acad Sci. 903:2000;24-33.
122. 3 receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol Pharmacol. 58:2000;477-482.
123. 2A-adenosine receptor via a rap1-dependent and via a p21(ras)-dependent pathway. J Biol Chem. 274:1999;25833-25841.
124. Sexl V., Mancusi G., Baumgartner-Parzer S., Schutz W., Freissmuth M. Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors. Br J Pharmacol. 114:1995;1577-1586.
125. 2A-adenosine receptor in primary human endothelial cells. J Biol Chem. 272:1997;5792-5799.
126. Shaban M., Smith R.A., Stone T.W. Purine suppression of proliferation of Sertoli-like TM4 cells in culture. Cell Prolif. 28:1995;673-682.
127. Shin C.Y., Jang E.S., Choi J.W., Ryu J.R., Kim W.K., Kim H.C., Choi C.R., Ko K.H. Adenosine and purine nucleosides protect rat primary astrocytes from peroxynitrite-potentiated, glucose deprivation-induced death: Preservation of intracellular ATP level. Exp Neurol. 176:2002;175-182.
128. 3 adenosine receptor agonist. Exp Cell Res. 243:1998;383-397.
129. 3 adenosine receptor activation and its suppression by isoproterenol. Exp Cell Res. 257:2000;111-126.
130. 3 adenosine receptor protects against doxorubicin-induced cardiotoxicity. J Mol Cell Cardiol. 33:2001;1249-1261.
131. 3 adenosine receptor. J Mol Cell Cardiol. 34:2002;493-507.
132. 2A adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem Pharmacol. 65:2003;493-501.
133. Spychala J. Tumor-promoting functions of adenosine. Pharmacol Ther. 87:2000;161-173.
134. Suh B.C., Kim T.D., Lee J.U., Seong J.K., Kim K.T. Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells. Br J Pharmacol. 134:2001;132-142.
135. Szondy Z. Adenosine stimulates DNA fragmentation in human thymocytes by Ca(2+)-mediated mechanisms. Biochem J. 304:1994;877-885.
136. Tanaka Y., Yoshihara K., Tsuyuki M., Kamiya T. Apoptosis induced by adenosine in human leukemia HL-60 cells. Exp Cell Res. 213:1994;242-252.
137. Tey H.B., Khoo H.E., Tan C.H. Adenosine modulates cell growth in human epidermoid carcinoma (A431) cells. Biochem Biophys Res Commun. 187:1992;1486-1492.
138. 6-(3-chlorobenzyl)-5′-N-methylcarboxamidoadenosine (Cl-IB-MECA) provides cardioprotection via KATP channel activation. Cardiovasc Res. 40:1998;138-145.
139. 3 adenosine receptor regulation. Biochim Biophys Acta. 1591:2002;55-62.
140. Van Daele P., Van Coevorden A., Roger P.P., Boeynaems J.M. Effects of adenine nucleotides on the proliferation of aortic endothelial cells. Circ Res. 70:1992;82-90.
141. van der Ploeg I., Ahlberg S., Parkinson F.E., Olsson R.A., Fredholm B.B. Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists. Naunyn-Schmiedeberg's Arch Pharmacol. 353:1996;250-260.
142. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res. 49:1989;6449-6465.
143. Vaupel P., Thews O., Hoeckel M. Treatment resistance of solid tumors: Role of hypoxia and anemia. Med Oncol. 18:2001;243-259.
144. 3 receptors and cerebroprotection in stroke. Ann NY Acad Sci. 939:2001;85-96.
145. Vossler M.R., Yao H., York R.D., Pan M.G., Rim C.S., Stork P.J. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell. 89:1997;73-82.
146. Wakade A.R., Przywara D.A., Wakade T.D. Intracellular, nonreceptor-mediated signalling by adenosine: Induction and prevention of neuronal apoptosis. Mol Neurobiol. 23:2001;137-153.
147. Walker B.A., Rocchini C., Boone R.H., Ip S., Jacobson M.A. Adenosine A2a receptor activation delays apoptosis in human neutrophils. J Immunol. 158:1997;2926-2931.
148. Wilkinson N., Rollason T.P. Recent advances in the pathology of smooth muscle tumours of the uterus. Histopathology. 39:2001;331-341.
149. Williams B.A., Blay J., Hoskin D.W. 2-Chloroadenosine stimulates granule exocytosis from mouse natural killer cells: Evidence for signal transduction through a novel extracellular receptor. Exp Cell Res. 233:1997;187-197.
150. Williams B.A., Manzer A., Blay J., Hoskin D.W. Adenosine acts through a novel extracellular receptor to inhibit granule exocytosis by natural killer cells. Biochem Biophys Res Commun. 231:1997;264-269.
151. Woodhouse E.C., Amanatullah D.F., Schetz J.A., Liotta L.A., Stracke M.L., Clair T. Adenosine receptor mediates motility in human melanoma cells. Biochem Biophys Res Commun. 246:1998;888-894.
152. Xaus J., Valledor A.F., Cardo M., Marques L., Beleta J., Palacios J.M., Celada A. Adenosine inhibits macrophage colony-stimulating factor-dependent proliferation of macrophages through the induction of p27kip-1 expression. J Immunol. 163:1999;4140-4149.
153. 3 antagonists. Biochem Biophys Res Commun. 232:1997;317-322.
154. 2A receptor antagonism. J Leukoc Biol. 67:2000;529-535.
155. Zhao Z.Q., Budde J.M., Morris C., Wang N.P., Velez D.A., Muraki S., Guyton R.A., Vinten-Johansen J. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J Mol Cell Cardiol. 33:2001;57-68.
156. 3 adenosine receptors in smooth, cardiac, and skeletal muscle is lethal to embryos. Microvasc Res. 63:2002;61-69.